<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The present study assessed the usefulness of brain natriuretic <z:chebi fb="7" ids="16670">peptide</z:chebi> in evaluating the cardiovascular status in children and grown-ups with congenital or <z:e sem="disease" ids="C0277564" disease_type="Disease or Syndrome" abbrv="">acquired disease</z:e> affected by <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0001635'>cardiac failure</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Brain natriuretic <z:chebi fb="7" ids="16670">peptide</z:chebi> should be included in the risk stratification of children with <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>In patients with <z:hpo ids='HP_0002564'>congenital heart defects</z:hpo>, it is useful to tailor the optimal medical strategy to individual patients </plain></SENT>
</text></document>